Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.88 Billion | 35.42 Billion | 33.99 Billion | 33.79 Billion | 36.27 Billion | 37.9 Billion |
| Cost of Revenue | 24.37 Billion | 20.86 Billion | 19.23 Billion | 18.92 Billion | 20.48 Billion | 21.95 Billion |
| Gross Profit | 16.51 Billion | 14.55 Billion | 14.75 Billion | 14.87 Billion | 15.79 Billion | 15.95 Billion |
| Operating Expenses | 12.65 Billion | 10.77 Billion | 11.39 Billion | 11.72 Billion | 11.61 Billion | 11.55 Billion |
| Selling, General and Administrative Expenses | 8.33 Billion | 7.35 Billion | 1.34 Billion | 1.48 Billion | 1.88 Billion | 1.81 Billion |
| Research and Development Expenses | 3.18 Billion | 2.48 Billion | 2.44 Billion | 3.06 Billion | 2.05 Billion | 1.76 Billion |
| Other Expenses | 1.14 Billion | 8.29 Billion | 7.6 Billion | 7.17 Billion | 7.67 Billion | 93 Million |
| Cost and Expenses | 37.03 Billion | 31.64 Billion | 30.63 Billion | 30.64 Billion | 32.1 Billion | 33.51 Billion |
| Operating Income | 3.85 Billion | 3.77 Billion | 3.34 Billion | 3.13 Billion | 4.17 Billion | 4.39 Billion |
| Interest Expense | 121 Million | 77 Million | 53 Million | 37 Million | 41 Million | 38 Million |
| Income Tax Expense | 963 Million | 1.02 Billion | 938 Million | 832 Million | 998 Million | 1.09 Billion |
| Earnings before Tax | 4.39 Billion | 3.72 Billion | 3.37 Billion | 2.91 Billion | 3.96 Billion | 4.47 Billion |
| Net Income | 3.43 Billion | 2.69 Billion | 2.43 Billion | 2.08 Billion | 2.96 Billion | 3.37 Billion |
| Earnings Per Share Basic | 141.35 | 110.98 | 90.52 | 66.92 | 97.02 | 112.67 |
| Earnings Per Share Diluted | 141.35 | 110.98 | 90.52 | 66.92 | 97.02 | 112.67 |
| Weighted Average Shares Outstanding | 24.3 Million | 24.29 Million | 26.86 Million | 31.15 Million | 30.52 Million | 29.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.3 Million | 24.29 Million | 26.86 Million | 31.15 Million | 30.52 Million | 29.92 Million |
| Gross Margin | 0.40 | 0.41 | 0.43 | 0.44 | 0.44 | 0.42 |
| EBIT Margin | 0.17 | 0.19 | 0.16 | 0.15 | 0.17 | 0.18 |
| Profit Margin | 0.08 | 0.08 | 0.07 | 0.06 | 0.08 | 0.09 |
| EBITDA | 6.88 Billion | 6.52 Billion | 5.45 Billion | 5.19 Billion | 6.3 Billion | 6.64 Billion |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.10 | 0.09 | 0.12 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 11.76 Billion | 10.64 Billion | 10.74 Billion | 11.4 Billion | 40.88 Billion | 10.25 Billion |
| Cost of Revenue | 7.48 Billion | 6.04 Billion | 7.19 Billion | 6.41 Billion | 24.37 Billion | 6.35 Billion |
| Gross Profit | 4.27 Billion | 4.59 Billion | 3.55 Billion | 4.98 Billion | 16.51 Billion | 3.9 Billion |
| Operating Expenses | 3.5 Billion | 3.01 Billion | 3.69 Billion | 3.52 Billion | 12.65 Billion | 3.32 Billion |
| Selling, General and Administrative Expenses | 3.5 Billion | 2.42 Billion | 2.47 Billion | 2.53 Billion | - | 2.35 Billion |
| Research and Development Expenses | - | 589 Million | 1.13 Billion | 922 Million | - | 894 Million |
| Other Expenses | - | -761 Million | 834 Million | 9 Million | 213 Million | 15 Million |
| Cost and Expenses | 10.99 Billion | 9.05 Billion | 10.88 Billion | 9.94 Billion | 37.02 Billion | 9.67 Billion |
| Operating Income | 772 Million | 1.58 Billion | -140 Million | 1.45 Billion | 3.85 Billion | 579 Million |
| Interest Expense | 54 Million | 43 Million | 40 Million | 28 Million | 107 Million | 27 Million |
| Income Tax Expense | 139 Million | 654 Million | 1.11 Billion | 205 Million | 963 Million | 75 Million |
| Earnings before Tax | 792 Million | 2.17 Billion | 3.85 Billion | 1.65 Billion | 4.39 Billion | 285 Million |
| Net Income | 653 Million | 1.51 Billion | 2.73 Billion | 1.45 Billion | 3.43 Billion | 210 Million |
| Earnings Per Share Basic | 26.86 | 62.44 | 112.69 | 59.79 | - | 8.64 |
| Earnings Per Share Diluted | 26.86 | 62.44 | 112.69 | 59.79 | - | 8.64 |
| Weighted Average Shares Outstanding | 24.31 Million | 24.31 Million | 24.3 Million | 24.3 Million | 24.3 Million | 24.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.31 Million | 24.31 Million | 24.3 Million | 24.3 Million | 24.3 Million | 24.3 Million |
| Gross Margin | 0.36 | 0.43 | 0.33 | 0.44 | 0.40 | 0.38 |
| EBIT Margin | 0.13 | 0.23 | 0.06 | 0.14 | - | 0.06 |
| Profit Margin | 0.06 | 0.14 | 0.25 | 0.13 | 0.08 | 0.02 |
| EBITDA | 1.52 Billion | 2.45 Billion | 694 Million | 1.61 Billion | - | 622 Million |
| Earnings Before Tax Margin | 0.07 | 0.15 | -0.01 | 0.13 | 0.09 | 0.06 |
ICCH
WLFD
301163
ADUS
017940
BC-PC